Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Carefirst Caremark / Lorlatinib

Lorlatinib — Carefirst Caremark

4 indications indexed for this drug.

Alk Positive Erdheim Chester Disease
View coverage criteria
Alk Positive Inflammatory Myofibroblastic Tumor Imt
View coverage criteria
Alk Rearrangement Positive Recurrent Advanced Or Metastatic
View coverage criteria
Relapsed Or Refractory Alk Positive Large B Cell Lymphoma
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.